Drug Description in Trials / DrugBank / KEGG DRUG

  

Search results

No. DrugBank 薬物名（臨床試験情報から抽出） KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1 Acellular nerve allograft 1件: Acellular nerve allograft---1件: 149 💬
2 Anakinra 1件: Anakinra1件: Anakinra 💬 2件: IL1R1,
IL1R2 💬 		15件: Amoebiasis, Cytokine-cytokine receptor interaction, Fluid shear stress and atherosclerosis, Hematopoietic cell lineage, Human T-cell leukemia virus 1 infection, Human cytomegalovirus infection, Inflammatory mediator regulation of TRP channels, MAPK signaling pathway, NF-kappa B signaling pathway, Osteoclast differentiation, Pathogenic Escherichia coli infection, Prostate cancer, Shigellosis, Th17 cell differentiation, Transcriptional misregulation in cancer 💬22件: 2, 13, 15, 19, 28, 37, 41, 46, 49, 50, 54, 56, 57, 84, 86, 97, 106, 107, 149, 153, 266, 299 💬
3 Baclofen 1件: BACLOFEN1件: Baclofen 💬 2件: GABBR1,
GABBR2 💬 		8件: Estrogen signaling pathway, GABAergic synapse, GnRH secretion, Morphine addiction, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Taste transduction, cAMP signaling pathway 💬8件: 2, 10, 13, 18, 65, 70, 149, 206 💬
4 Botulinum toxin type A 5件: Botulinum toxin A; BOTULINUM TOXIN TYPE A; IncobotulinumtoxinA; Onabotulinumtoxin A; OnabotulinumtoxinA4件: Botulinum toxin type A ,
OnabotulinumtoxinA ,
AbobotulinumtoxinA ,
Incobotulinumtoxin A 💬 		1件: SNAP25 💬 2件: Insulin secretion, Synaptic vesicle cycle 💬13件: 2, 5, 6, 7, 13, 15, 17, 47, 70, 113, 149, 171, 226 💬
5 Brivaracetam 1件: BRIVARACETAM1件: Brivaracetam 💬 1件: SV2A 💬 1件: ECM-receptor interaction 💬2件: 149, 309 💬
6 Edonerpic 1件: Edonerpic---1件: 149 💬
7 Ezetimibe 1件: Ezetimibe1件: Ezetimibe 💬 1件: NPC1L1 💬 1件: Fat digestion and absorption 💬5件: 49, 79, 93, 149, 260 💬
8 Fenfluramine 2件: Fenfluramine; Fenfluramine hydrochloride2件: Fenfluramine hydrochloride ,
Fenfluramine 💬 		5件: HTR1D,
HTR2A,
HTR2C,
SIGMAR1,
SLC6A4 💬 		11件: Amyotrophic lateral sclerosis, Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Pathways of neurodegeneration - multiple diseases, Serotonergic synapse, Synaptic vesicle cycle, Taste transduction, cAMP signaling pathway 💬6件: 140, 143, 144, 145, 149, 156 💬
9 Lacosamide 1件: Lacosamide1件: Lacosamide 💬 2件: SCN3A,
SCN9A 💬 		1件: Taste transduction 💬4件: 2, 46, 149, 298 💬
10 Levetiracetam 1件: Levetiracetam1件: Levetiracetam 💬 1件: SV2A 💬 1件: ECM-receptor interaction 💬7件: 2, 4, 6, 13, 34, 149, 307 💬
11 Melatonin 1件: Melatonin1件: Melatonin 💬 2件: MTNR1A,
MTNR1B 💬 		2件: Circadian entrainment, Neuroactive ligand-receptor interaction 💬18件: 2, 6, 8, 13, 37, 46, 49, 72, 78, 86, 90, 96, 97, 145, 149, 159, 202, 265 💬
12 Oxygen 1件: Oxygen1件: Oxygen 💬 --30件: 6, 13, 15, 19, 22, 36, 46, 49, 70, 71, 85, 86, 88, 90, 96, 97, 129, 149, 168, 193, 211, 226, 230, 235, 269, 271, 294, 298, 299, 330 💬
13 Padsevonil 1件: Padsevonil1件: Padsevonil 💬 3件: SV2A,
SV2B,
SV2C 💬 		1件: ECM-receptor interaction 💬1件: 149 💬
14 Psilocybin 2件: Psilocybin; Psilocybine1件: Psilocybin 💬 1件: HTR2A 💬 6件: Calcium signaling pathway, Gap junction, Inflammatory mediator regulation of TRP channels, Neuroactive ligand signaling, Neuroactive ligand-receptor interaction, Serotonergic synapse 💬5件: 2, 6, 13, 149, 206 💬
15 Sodium oxybate 1件: Sodium Oxybate1件: Sodium oxybate 💬 --2件: 6, 149 💬
16 Tocilizumab 2件: BAT1806; TOCILIZUMAB1件: Tocilizumab 💬 1件: IL6R 💬 11件: Coronavirus disease, Cytokine-cytokine receptor interaction, HIF-1 signaling pathway, Hematopoietic cell lineage, Human cytomegalovirus infection, JAK-STAT signaling pathway, Non-alcoholic fatty liver disease, PI3K-Akt signaling pathway, Pathways in cancer, Th17 cell differentiation, Viral protein interaction with cytokine and cytokine receptor 💬26件: 2, 11, 13, 40, 41, 42, 43, 44, 46, 49, 50, 51, 53, 54, 55, 56, 65, 86, 107, 149, 153, 223, 266, 271, 298, 331 💬
17 Triheptanoin 1件: TRIHEPTANOIN1件: Triheptanoin 💬 --12件: 2, 8, 65, 149, 156, 248, 256, 257, 317, 318, 324, 344 💬